Patent · US Expired

Sushi peptide multimer

US7763704B2 · kind B2 · utility

70Cited by
1References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 2, 2004
Grant dateJul 27, 2010
Priority date
Expiry dateFeb 27, 2026

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S930/28
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Endotoxin, also known as lipopolysaccharides (LPS), is the major mediator of septic shock due to Gram-negative bacterial infection. Chemically synthesized S3 peptide, derived from Sushi3 domain of Factor C, which is the endotoxin-sensitive serine protease of the limulus coagulation cascade, binds and neutralizes LPS activity. Fluorescent tagged-S3 is shown to detect LPS-containing bacteria. For large-scale production of S3 and to mimic other pathogen-recognizing molecules, tandem multimers of the S3 gene were constructed and expressed in E. coli. Tetramer of S3 for example is shown to display an enhanced inhibitory effect on LPS-induced activities. An affinity matrix based on tetramer of S3 is also shown to be particularly efficient at removing LPS.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.